MMIRF
Price:
$0.0546
Market Cap:
$73.05M
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development...[Read more]
Industry
Biotechnology
IPO Date
2009-11-03
Stock Exchange
PNK
Ticker
MMIRF
According to MedMira Inc.’s latest financial reports and current stock price. The company's current ROE is 19.92%. This represents a change of 303.45% compared to the average of 4.94% of the last 4 quarters.
The mean historical ROE of MedMira Inc. over the last ten years is 24.50%. The current 19.92% ROE has changed -18.68% with respect to the historical average. Over the past ten years (40 quarters), MMIRF's ROE was at its highest in in the July 2016 quarter at 26.91%. The ROE was at its lowest in in the October 2020 quarter at -4.82%.
Average
24.50%
Median
18.12%
Minimum
4.30%
Maximum
67.32%
Discovering the peaks and valleys of MedMira Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 244.90%
Maximum Annual ROE = 67.32%
Minimum Annual Increase = -67.30%
Minimum Annual ROE = 4.30%
Year | ROE | Change |
---|---|---|
2024 | 18.44% | 3.61% |
2023 | 17.80% | 20.08% |
2022 | 14.82% | 244.90% |
2021 | 4.30% | -67.30% |
2020 | 13.14% | -15.66% |
2019 | 15.58% | -29.22% |
2018 | 22.02% | -25.67% |
2017 | 29.62% | -56.01% |
2016 | 67.32% | 60.60% |
2015 | 41.92% | -26.88% |
The current ROE of MedMira Inc. (MMIRF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.02%
5-year avg
13.70%
10-year avg
24.50%
MedMira Inc.’s ROE is greater than Oxford Cannabinoid Technologies Holdings Plc (-86.76%), less than Neurobiological Technologies, Inc. (0%), greater than Pharming Group N.V. (-8.08%), greater than Kane Biotech Inc. (-94.49%), less than Health Sciences Group, Inc. (0%),
Company | ROE | Market cap |
---|---|---|
-86.76% | $3.05M | |
0% | $2.70K | |
-8.08% | $651.22M | |
-94.49% | $9.26M | |
0% | $187.09K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MedMira Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MedMira Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MedMira Inc.'s ROE?
How is the ROE calculated for MedMira Inc. (MMIRF)?
What is the highest ROE for MedMira Inc. (MMIRF)?
What is the 3-year average ROE for MedMira Inc. (MMIRF)?
What is the 5-year average ROE for MedMira Inc. (MMIRF)?
How does the current ROE for MedMira Inc. (MMIRF) compare to its historical average?